BeiGene, Ltd. (6160.HK)
6160.HK Stock Price Chart
Explore BeiGene, Ltd. interactive price chart. Choose custom timeframes to analyze 6160.HK price movements and trends.
6160.HK Company Profile
Discover essential business fundamentals and corporate details for BeiGene, Ltd. (6160.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
8 Aug 2018
Employees
11.00K
Website
http://www.beigene.comCEO
John V. Oyler
Description
BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
6160.HK Financial Timeline
Browse a chronological timeline of BeiGene, Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 10 Nov 2025
Earnings released on 6 Aug 2025
EPS came in at $0.55 surpassing the estimated $0.25 by +118.90%, while revenue for the quarter reached $10.33B , beating expectations by +658.62%.
Earnings released on 7 May 2025
EPS came in at $0.01 surpassing the estimated -$0.35 by +101.95%, while revenue for the quarter reached $8.68B , missing expectations by -1.12%.
Earnings released on 24 Feb 2025
EPS came in at -$0.85 falling short of the estimated -$0.61 by -40.92%, while revenue for the quarter reached $8.76B , beating expectations by +743.01%.
Earnings released on 13 Nov 2024
EPS came in at -$0.69 falling short of the estimated -$0.67 by -3.87%, while revenue for the quarter reached $7.78B , beating expectations by +647.44%.
Earnings released on 7 Aug 2024
EPS came in at -$0.69 surpassing the estimated -$1.32 by +47.48%, while revenue for the quarter reached $7.26B , beating expectations by +14.62%.
Earnings released on 8 May 2024
EPS came in at -$1.45 surpassing the estimated -$1.86 by +22.17%, while revenue for the quarter reached $5.88B , beating expectations by +13.13%.
Earnings released on 27 Feb 2024
EPS came in at -$0.27 surpassing the estimated -$0.37 by +27.03%, while revenue for the quarter reached $4.95B , missing expectations by -0.06%.
Earnings released on 10 Nov 2023
EPS came in at -$1.20 falling short of the estimated -$0.36 by -233.33%, while revenue for the quarter reached $6.12B , beating expectations by +31.00%.
Earnings released on 2 Aug 2023
EPS came in at -$28.54 falling short of the estimated -$2.02 by -1.31K%, while revenue for the quarter reached $4.66B , beating expectations by +19.02%.
Earnings released on 5 May 2023
EPS came in at -$2.02 surpassing the estimated -$2.21 by +8.68%, while revenue for the quarter reached $3.52B , beating expectations by +0.84%.
Earnings released on 28 Feb 2023
EPS came in at -$0.33 surpassing the estimated -$0.57 by +42.11%, while revenue for the quarter reached $2.97B , missing expectations by -2.44%.
Earnings released on 10 Nov 2022
EPS came in at -$3.25 falling short of the estimated -$2.36 by -37.82%, while revenue for the quarter reached $3.04B , beating expectations by +0.50%.
Earnings released on 4 Aug 2022
EPS came in at -$3.35 falling short of the estimated -$2.42 by -38.61%, while revenue for the quarter reached $2.68B , beating expectations by +9.01%.
Earnings released on 5 May 2022
EPS came in at -$0.33 surpassing the estimated -$1.68 by +80.36%, while revenue for the quarter reached $2.40B , beating expectations by +17.73%.
Earnings released on 26 Feb 2022
EPS came in at -$3.70 falling short of the estimated -$2.98 by -23.95%, while revenue for the quarter reached $1.67B , missing expectations by -0.26%.
Earnings released on 5 Nov 2021
EPS came in at -$2.67 , while revenue for the quarter reached $1.61B .
Earnings released on 6 Aug 2021
EPS came in at -$0.40 , while revenue for the quarter reached $1.16B .
Earnings released on 7 May 2021
EPS came in at $0.05 , while revenue for the quarter reached $4.71B .
Earnings released on 26 Feb 2021
EPS came in at -$3.10 , while revenue for the quarter reached $776.06M .
Earnings released on 6 Nov 2020
EPS came in at -$0.37 surpassing the estimated -$4.06 by +90.89%, while revenue for the quarter reached $705.87M .
6160.HK Stock Performance
Access detailed 6160.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.